📣 VC round data is live. Check it out!
- Public Comps
- Medmix
Medmix Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medmix and similar public comparables like ElringKlinger, Tess Holdings Co, Columbus McKinnon, AngioDynamics and more.
Medmix Overview
About Medmix
Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery, and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of its revenue is from the Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways, and aerospace), electronics assembly, infrastructure, and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas, and Asia-Pacific.
Founded
2021
HQ

Employees
2.7K
Website
Financials (LTM)
EV
$767M
Valuation Multiples
Start free trialMedmix Financials
Medmix reported last 12-month revenue of $581M and EBITDA of $115M.
In the same LTM period, Medmix generated $214M in gross profit, $115M in EBITDA, and $24M in net income.
Revenue (LTM)
Medmix P&L
In the most recent fiscal year, Medmix reported revenue of $579M and EBITDA of $112M.
Medmix is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 19%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Medmix Stock Performance
Medmix has current market cap of $461M, and enterprise value of $767M.
Market Cap Evolution
Medmix's stock price is $11.35.
Medmix share price decreased by 2.0% in the last 30 days, and by 26.3% in the last year.
Medmix has an EPS (earnings per share) of $0.48.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $767M | $461M | -0.1% | -2.0% | 2.7% | -26.3% | $0.48 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedmix Valuation Multiples
Medmix trades at 1.3x EV/Revenue multiple, and 6.7x EV/EBITDA.
EV / Revenue (LTM)
Medmix Financial Valuation Multiples
As of June 4, 2026, Medmix has market cap of $461M and EV of $767M.
Medmix has a P/E ratio of 19.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medmix Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Medmix Margins & Growth Rates
Medmix grew revenue by 1% and EBITDA by 6% in the last fiscal year.
In the most recent fiscal year, Medmix reported gross margin of 36%, EBITDA margin of 19%, and net margin of 3%.
Medmix Margins
Medmix Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Medmix Operational KPIs
Medmix's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Medmix's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medmix's Rule of X is 27% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Medmix Competitors
Medmix competitors include ElringKlinger, Tess Holdings Co, Columbus McKinnon, AngioDynamics, Standard BioTools, Revenio Group, L.B. Foster, The Beauty Tech Group, Medistim and 2seventy bio.
Most Medmix public comparables operate across Industrial Parts, Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.2x | 0.2x | 2.5x | 2.3x | |||
| 3.7x | 3.0x | 25.3x | - | |||
| 0.9x | 0.7x | 5.8x | 3.9x | |||
| 1.4x | 1.3x | 54.4x | 33.3x | |||
| 0.3x | 0.3x | (0.4x) | (0.6x) | |||
| 3.3x | 2.9x | 11.6x | 11.3x | |||
| 1.0x | 1.0x | 13.4x | 12.9x | |||
| 2.3x | 2.1x | 8.5x | 8.1x | |||
This data is available for Pro users. Sign up to see all Medmix competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medmix
| When was Medmix founded? | Medmix was founded in 2021. |
| Where is Medmix headquartered? | Medmix is headquartered in Switzerland. |
| How many employees does Medmix have? | As of today, Medmix has over 2K employees. |
| Is Medmix publicly listed? | Yes, Medmix is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of Medmix? | Medmix trades under MEDX ticker. |
| When did Medmix go public? | Medmix went public in 2021. |
| Who are competitors of Medmix? | Medmix main competitors include ElringKlinger, Tess Holdings Co, Columbus McKinnon, AngioDynamics, Standard BioTools, Revenio Group, L.B. Foster, The Beauty Tech Group, Medistim, 2seventy bio. |
| What is the current market cap of Medmix? | Medmix's current market cap is $461M. |
| What is the current revenue of Medmix? | Medmix's last 12 months revenue is $581M. |
| What is the current revenue growth of Medmix? | Medmix revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Medmix? | Current revenue multiple of Medmix is 1.3x. |
| What is the current EBITDA of Medmix? | Medmix's last 12 months EBITDA is $115M. |
| What is Medmix's EBITDA margin? | Medmix's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Medmix? | Current EBITDA multiple of Medmix is 6.7x. |
| What is the current FCF of Medmix? | Medmix's last 12 months FCF is $28M. |
| What is Medmix's FCF margin? | Medmix's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Medmix? | Current FCF multiple of Medmix is 27.9x. |
| How many companies Medmix has acquired to date? | Medmix hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Medmix has invested to date? | Medmix hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Medmix
Lists including Medmix
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.